scholarly journals Relationship between Serum Selenium and Copper Levels with Insulin Resistance in Patients with Diabetes type 2: A Case Control Study

Author(s):  
Vahid Pouresmaeil
2011 ◽  
Vol 5 (4) ◽  
Author(s):  
Ren-Nan Feng ◽  
Cheng Wang ◽  
Chang-Hao Sun ◽  
Fu-Chuan Guo ◽  
Chen Zhao ◽  
...  

AbstractBackground: Visceral adipose tissue-derived serine protease inhibitor (vaspin) is a novel adipocytokine. Several studies have indicated that vaspin may exert an important role in the development of metabolic disorders.Objective: Evaluate serum vaspin and its relation to clinical parameters in newly and previously diagnosed Chinese type 2 diabetes mellitus (T2DM) females as a case-control study.Materials and methods: One hundred twenty female participants (newly and previously diagnosed T2DM patients) were recruited from an affiliated hospital of Harbin Medical University. Sixty healthy female volunteers from various communities were included as controls. Anthropometric parameters, serum fasting blood glucose, fasting insulin, lipid profile, HbA1c, and vaspin were measured in each participant.Results: Serum vaspin levels were significantly lower in previously diagnosed T2DM patients (0.51±0.29 ng/mL) than in newly diagnosed T2DM patients (0.62±0.28 ng/mL) and healthy controls (0.69±0.31 ng/mL). However, there was no difference in serum vaspin between newly diagnosed T2DM patients and healthy controls. In multiple linear regression analysis, serum vaspin was significantly and positively associated with HbA1c in both newly and previously diagnosed T2DM patients, negatively associated with homeostasis model assessment of insulin resistance in previously diagnosed patients, and positively correlated with age and body mass index in healthy controls.Conclusion: Serum vaspin was significantly lower in previously diagnosed T2DM patients than in newly diagnosed T2DM patients and healthy controls. Serum vaspin might be a predictor of poor glucose control and insulin resistance in T2DM.


2021 ◽  
Vol 8 (1) ◽  
pp. 1-14
Author(s):  
Renata M. Pinto ◽  
◽  
Jakeline S. Fortes ◽  
Rúbia V. Monteiro ◽  
Nygell S. Alves ◽  
...  

Background Genetic polymorphisms that affect the availability and secretion of dopamine can affect the risk of obesity. Objectives To investigate the relationship between pediatric obesity and cardiovascular risk factors (CRF) with the polymorphisms of “Fat Mass and Obesity Associated” (FTO) rs9939609, “Dopamine Receptor type 2” (DRD2) rs6277 and “Ankyrin Repeat and Kinase Domain Containing 1” (ANKK1) rs18000497 genes. Methods Case-Control study conducted with 226 pediatric patients from 5 to 16-years of age. The two main groups, Obese (O) and Eutrophic (E), were subdivided according to the value of HOMA-IR into obese with insulin resistance (ORI) or insulin sensitivity (OSI) and eutrophic resistant (ERI) or sensitive (ESI) to insulin. According to the presence of two or more CRF, they were subdivided into metabolically unhealthy or metabolically healthy groups: Obese Metabolically Unhealthy (OMU), Obese Metabolically Healthy (OMH), Eutrophic Metabolically Unhealthy (EMU) and Eutrophic Metabolically Healthy (EMH). Polymorphisms were determined by real-time Polymerase Chain Reaction (PCR) or Restriction Fragment Length Polymorphisms (PCR-RFLP). Results In the obese group, the higher the number of risk alleles of FTO and ANKK1 genes isolated and the three genes combined, the higher the mean BMI (p<0.0001). Regarding the FTO gene: the frequency of the risk allele was: 57.7%-ERI, 37.4%-ESI (p=0.048), and the homozygous wild genotype was: 29.5%-OMU, 37.5%-OMH (p=0.02). Regarding the DRD2 gene: the genotypes with the risk allele were present in 84.6%-OMU and 67.5%-OMH (p=0.031). Regarding the ANKK1 gene: the frequency of the homozygous risk genotype was current in 15.4%-ERI and 13.5%-ESI (p<0.0001) and 62.5%-EMU and 41.5%-OMH (p=0.031). Conclusion Risk alleles of FTO, DRD2 and ANKK1 genes had an additive effect on the outcome of pediatric obesity in Brazilian children and conferred a higher risk of insulin resistance (FTO and ANKK1) and CRF.


PLoS ONE ◽  
2017 ◽  
Vol 12 (4) ◽  
pp. e0175388 ◽  
Author(s):  
Linda Ahenkorah Fondjo ◽  
William K. B. A. Owiredu ◽  
Samuel Asamoah Sakyi ◽  
Edwin Ferguson Laing ◽  
Michael Acquaye Adotey-Kwofie ◽  
...  

2004 ◽  
Vol 89 (9) ◽  
pp. 4371-4376 ◽  
Author(s):  
Aneliya Parvanova ◽  
Ilian Iliev ◽  
Marco Filipponi ◽  
Borislav D. Dimitrov ◽  
Monica Vedovato ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (2) ◽  
pp. 477 ◽  
Author(s):  
Chia-Wen Lu ◽  
Hao-Hsiang Chang ◽  
Kuen-Cheh Yang ◽  
Chien-Hsieh Chiang ◽  
Chien-An Yao ◽  
...  

Few studies have investigated the association between selenium and metabolic syndrome. This study aimed to explore the associations between the serum selenium level and metabolic syndrome as well as examining each metabolic factor. In this case-control study, the participants were 1165 adults aged ≥40 (65.8 ± 10.0) years. Serum selenium was measured by inductively coupled plasma-mass spectrometry. The associations between serum selenium and metabolic syndrome were examined by multivariate logistic regression analyses. The least square means were computed by general linear models to compare the serum selenium levels in relation to the number of metabolic factors. The mean serum selenium concentration was 96.34 ± 25.90 μg/L, and it was positively correlated with waist circumference, systolic blood pressure, triglycerides, fasting glucose, and homeostatic model assessment insulin resistance (HOMA-IR) in women, but it was only correlated with fasting glucose and HOMA-IR in men. After adjustment, the odds ratios (ORs) of having metabolic syndrome increased with the selenium quartile groups (p for trend: <0.05), especially in women. The study demonstrated that the serum selenium levels were positively associated with metabolic syndrome following a non-linear dose–response trend. Selenium concentration was positively associated with insulin resistance in men and women, but it was associated with adiposity and lipid metabolism in women. The mechanism behind this warrants further confirmation.


2020 ◽  
Author(s):  
Hyder Osman Mirghani

Abstract Objectives: There is an increasing awareness about the association of the restless leg syndrome (RLS) with type 2 diabetes, the present study assessed RLS and its associations among patients with diabetes. Results: This case-control study conducted among 160 subjects (eighty-two patients with diabetes and 78 controls) attending a diabetic clinic in Omdurman, Sudan during the period from June 2018 to September 2019. A structured questionnaire based on restless syndrome, demographic data, and diabetes complications was used. The neck circumference was measured to assess adiposity, and a blood sample was taken for the glycated hemoglobin estimation.There were 82 patients with type 2 diabetes and 78 controls matched for age and sex, the restless syndrome was higher among patients with diabetes (31.7% vs. 10.3%%) with significant statistical difference, P-<0.05, A direct positive relationship was found between restless leg syndrome and diabetic neuropathy (Wald =5.48, P-value=0.019, 95% CI 1.70-410.76, no relationship was found between RLS, diabetic retinopathy, HbA1 c , sex, and neck circumference, P-values (0.757, 0.804, 0.317, and 0.361 respectively). RLS was prevalent among patients with type 2 diabetes and related to diabetic neuropathy, no relationship was found between restless syndrome, age, sex, neck circumference, HbA1 c , and retinopathy.


PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0251697
Author(s):  
Fahime Zeinali ◽  
Seyed Mohsen Aghaei Zarch ◽  
Alireza Jahan-Mihan ◽  
Seyed Mehdi Kalantar ◽  
Mohammad Yahya Vahidi Mehrjardi ◽  
...  

The prevalence of type 2 diabetes mellitus (T2DM) is increasing dramatically worldwide. Dysregulation of microRNA (miRNA) as key regulators of gene expression, has been reported in numerous diseases including diabetes. The aim of this study was to investigate the expression levels of miRNA-122, miRNA-126-3p and miRNA-146a in diabetic and pre-diabetic patients and in healthy individuals, and to determine whether the changes in the level of these miRNAs are reliable biomarkers in diagnosis, prognosis, and pathogenesis of T2DM. Additionally, we examined the relationship between miRNA levels and plasma concentrations of inflammatory factors including tumor necrosis factor alpha (TNF-α) and interleukin 6 (Il-6) as well as insulin resistance. In this case-control study, participants (n = 90) were allocated to three groups (n = 30/group): T2DM, pre-diabetes and healthy individuals as control (males and females, age: 25–65, body mass index: 25–35). Expression of miRNA was determined by real-time polymerase chain reaction (RT-PCR). Furthermore, plasma concentrations of TNF-α, IL-6 and fasting insulin were measured by enzyme-linked immunosorbent assay. Homeostatic model assessment for insulin resistance (HOMA-IR) was calculated as an indicator of insulin resistance. MiRNA-122 levels were higher while miRNA-126-3p and miRNA-146a levels were lower in T2DM and pre-diabetic patients compared to control (p<0.05). Furthermore, a positive correlation was found between miRNA-122 expression and TNF-α (r = 0.82), IL-6 (r = 0.83) and insulin resistance (r = 0.8). Conversely, negative correlations were observed between miRNA-126-3p and miRNA-146a levels and TNF-α (r = -0.7 and r = -0.82 respectively), IL-6 (r = -0.65 and r = -0.78 respectively) as well as insulin resistance (r = -0.67 and r = -0.78 respectively) (all p<0.05). Findings of this study suggest the miRNAs can potentially contribute to the pathogenesis of T2DM. Further studies are required to examine the reproducibility of these findings.


Sign in / Sign up

Export Citation Format

Share Document